AtriCure Reports First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
AtriCure (ATRC) Tops Q1 EPS by 20c; Offers FY23 Revenue Guidance
May 2, 2023 4:05 PM EDTAtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.14), $0.20 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $93.5 million versus the consensus estimate of $87.53 million.
GUIDANCE:
AtriCure sees FY2023 revenue of $385-392 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
... More